• Small Molecules
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Stock Exchange Disclosures

Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR) Press Release- Media Release
Announcement under Regulation 30 (LODR)-Investor Presentation
Outcome and Quick Results of the Board Meeting-October 20,2021
Conference call for Analysts and Investors to beheld on October 21, 2021
Intimation of Board Meeting and Trading Window Closure
Investor meeting with Aikya Investment Management
Investor meeting with Aikya Investment Management
Investor Meeting with Canara Robeco and Genesis Investment
Investor Meeting with PGIM MF
Update on Interim disbursements from Insurer towards the loss from fire incident reported in December 2016
Investor Call with FSSA Investment Managers
Investor Call with Bay Capital
Intimation of Schedule of Meetings with Institutional Investors
Advertisement in Newspapers – Financial Results Q3 FY21
Outcome of Board Meeting - Q3FY21
Intimation of Q3FY21 Investor Presentation
Q3FY21 Press Release-Intimation
Conference call for Analysts and Investors to be held on January 21,2021
Advertisement in Newspapers – Notice of Board Meeting to be held on January 20, 2021
Q4FY19 Board Meeting Intimation
Q4FY19 Press Release March 2019-Intimation
The Outcome of Board Meeting- Q4FY19
Investor Presentation March 2019- Intimation
Resignation of CS -Intimation
Investor Meetings with Pari Washington Company Advisors, Jefferies ASEAN and India Corporate Access Days, Axis Capital 12th Annual Conference, B and K Annual Conference
Investor Meeting with Canara Robeco Asset Management Company Ltd.
Investor Meeting with Seven Canyons Advisors
Postal Ballot Notice Intimation May 2019
Investor Meeting with Mondrian Investment Partners.
Sale of Share by Promoter to Achieve Minimum Public Shareholding
Completion of Sale of Shares by Promoter
Syngene Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services- Press Release
Intimation of AGM 2018
Intimation of AGM 2018: Newspaper Ad
Q1FY19 Board Meeting Intimation
The outcome of BM -Audited Financial Results Q1FY19
Investor Presentation June 2018- Intimation
Q1FY19 Press Release June2018-Intimation
Voting Results AGM July 2018
Investors Meetings- Dated till May 29th
Intimation of AGM 2017
Intimation of AGM 2017: Newspaper Ad
Board Meeting Intimation July27 2017
Board Meeting Intimation: Newspaper Ad
Intimation-Outcome of BM -Audited Financial Results
Syngene -Voting results under Regulation 44(3) of SEBI
Syngene 24th AGM Proceeding July 2017
Intimation-Outcome of BM -Audited Financial Results
New Appointment in Board
Board Meeting Intimation: 21st,July-2016
Financial Results Q1 FY17
Investors Meeting with Ambit Capital, SBI Life Insurance Co Ltd, Motilal Oswal 12th Annual Global Investor Confrence 2016, Motilal Oswal Roadshow in Asia , Axis Capital 10th Annual Conference
Syngene-SARC PressRelease,2016
Syngene strand PressRelease,2016
Investors Meeting with Dalal & Broacha Stock Broking Private Limited,Haitong Securities India Private Limited & Geneva Advisors, LLC
Board Meeting Intimation: 20th,October-2016
Board Meeting Intimation: Newspaper Ad
Investor Presentation-Oct2016
Investors Meeting with Mondrian Investment Partners, Mawer Investments, I Wealth Management, Templeton Asset Management Limited, Matthews India Fund, Marathon Asset Management, Matthews Asia
Syngene Postal Ballot Results - 2015
Intimation of Scheduled Meetings
Change in KMP
Interim Dividend Intimation to Stock Exchange
Syngene Dividend Declaration- March 2016
Investors Presentation at Jefferies India Corporate Day- March 2016
Investors Meeting with Karst Peak Capital, Batlivala &Karani, Cartica Capital
Investors Meeting with BlackRock UK, Nomura Securities, Ward Ferry Management Ltd
Investors Meeting with Nomura Securities is cancelled
Intimation of Board Meeting

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details